Age-related macular degeneration (AMD) is the leading cause of vision loss in people over the age of 50, affecting approximately 1.4 million Canadians. This February, join us for AMD Awareness Month and a special roundtable highlighting new developments in AMD research & treatments.
In this webinar we will be joined by three speakers who will cover the following topics:
New AMD research funded by FBC
New research into dry AMD & geographic atrophy
What are biosimilars and how will they impact AMD patients
There will be time for Q&A. If you have questions in advance or need any assistance with registration, please email email@example.com